Aspire Artemis Foundation Hosts Global STE(A)M Conference at United Nations House in Barbados

Aspire Artemis Foundation Hosts Global STE(A)M Conference at United Nations House in Barbados

https://www.aspireartemis.org/ Bridgetown, Barbados — On Friday, May 9, 2025, the Aspire Artemis Foundation, in partnership with local and international stakeholders, will host its next installment of Conversations in STEAM at the United…
L’Oréal Groupe Unveils L’Oréal Cell BioPrint, a Revolution in Consumer Skin Intelligence Rooted in the Field of Longevity Science, at CES 2025

L’Oréal Groupe Unveils L’Oréal Cell BioPrint, a Revolution in Consumer Skin Intelligence Rooted in the Field of Longevity Science, at CES 2025

  Portable lab-on-a-chip device uses cutting-edge science to enable consumers to understand their skin’s aging trajectory and gain insights into the skincare that works best for their needs   LAS VEGAS, January 6, 2025 – Today at CES® 2025, L'Oréal Groupe unveiled L’Oréal Cell BioPrint, a tabletop hardware device that provides personalized skin analysis in just five minutes, using advanced proteomics – the study of how protein composition in the human body affects skin aging.   L’Oréal Cell BioPrint is made possible by L'Oréal's Longevity Integrative Scienceä, a groundbreaking approach that reveals how mechanisms in the human body can affect skin’s appearance, and through an exclusive partnership with Korean startup NanoEnTek. L’Oréal Cell BioPrint produces a personalized skin assessment in minutes including:   Skin's BiologicalAge: How fast is skin aging? L’Oréal Cell BioPrint can calculate skin's age and provide personalized advice on how to slow down the appearance of aging.  …
Parkinson’s Discovery Suggests We May Already Have an FDA-Approved Treatment

Parkinson’s Discovery Suggests We May Already Have an FDA-Approved Treatment

(Sciepro/Science Photo Library/Getty Images) Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for Parkinson's disease from cell-to-cell in the brain. Promisingly, an…